holtz-eakin and ms. feldman. hr 2064 is -- i'm worried that the bill will have unintended consequences for patients. manufacturers of drugs and -- often provide samples to providers that help low income patients who may have trouble accessing a therapy. either because they lack insurance or the insurance does not provide robust coverage for a drug or device. yet the bill places new reporting requirements on manufacturers. my question is, doesn't this bill create a perverse incentive for manufacturers to not provide samples to physician offices and can you describe how low-income patients benefit from samples provided by drug and device manufacturers and any other unintended consequences? i throw that out to you. >> thank you for that question. very briefly, i think there is a real question as to whether this could cause the lessening of provision of samples. i would also note that significant amount of information is already reported to the fda with regard to samples. in some respects, there is creating a duplica

douglas holtz-eakin, former cbo director.ing up this afternoon, live coverage of the fed decision, and then chairman powell's news conference on bloomberg television. russia looms larger in the american consciousness than perhaps at any time of our history. we speak to the author of an important book on why that works just fine for vladimir putin. this is bloomberg. ♪ david: you are watching "balance of power." i'm david westin. russian influence in europe, the middle east, and even in the 2016 presidential election, and now we may be even seeing it in venezuela. saidtary of state pompeo yesterday that missouri was ready to leave this morning, but as we understand, russians indicated he should stay, something that the russian foreign policy called take news. joining us now is professor of government and foreign service at georgetown. she is the director of the georgetown center for eurasian, russia, and eastern studies. she is also the author of the new book "putin's world." there was a headline that crotch from the headline

let me change gears here for just a second and ask doctor miller and doctor holtz-eakin earlier you were asked about one of the parts of the bill that says drug companies would have to give notification before they went up on a price and there was concern about stockpiling. are you familiar with the pricing and how that works? >> yes. >> do you agree any assessment that if we know that a pharmacyy knows the price is going to be up that there is a possibility that they stockpile of those drugs to buy them at a lower cost and also to be able to keep them so they can solve them at a higher price? >> i want to process by saying i don't think that the transparency has a huge effect. to the question you're asking i think i would say that i would not do a prior notice for the reasons that you are raising. >> i would be concerned about that as well. >> i can tell you from first-hand experience having been in business before they became a member of congress that is something we did all the time we knew the price was going up so there is a danger than they would flee very carefully be careful with

and doctor douglas eakin president of the american actions reform. woke up to you and take you to each one of you again and joining us today. at this time the chair will recognize each witness for five minutes in the light that means the most is a red light. when you're driving, you stop. and i think several of you have already testified so you know what the system is. so now i would like to call long ms. holder small you're recognized for five minutes of your testimony and we thank you again for being here with us today, you may begin. >> thank you very much and good morning. distinguished members of the subcommittee and thank you chairman's alone and ranking member walden and wait ranking member to testify today. i am a senior vice president at the pharmaceutical research and manufacturers of america or pharma. as many of you know pharma represents the leading research-based biopharmaceutical company. since year 2000, our companies have collectively invested half a trillion dollars in the search for new treatment in new cures including more than $7

at a recent meeting, amanda eakin asked about ways to reach the zero goal of no traffic deaths by 2024. >> the piece i was raising was whether or not we could look at the impact that banning right turns on red would have on pedestrian safety. >> reporter: she says the walk sign on traffic signals gives the impression it's safe when sometimes it isn't. other cities have already explored the idea. now sfmta will take a look. >> i think it would be a little safer for everyone. >> reporter: now at this point, this is all just in the discussion phase. i asked amanda if this would be all over the city or if her idea was just high-injury corridors. she said at this point, it is just to early to say. of course it would need approval before it would move forward. reporting live in san francisco, christie smith, nbc bay area news. >>> the san jose city council is getting a lot of push back about metal detectors in city hall. a council member is push being the idea and says they are needed at council chambers for safety. but silicon valley advocates say that's undemocratic and hostile to the publ

for more we want to bring in douglas holtz-eakin. like what you wrote today with respect to this conversation, dispute resolution done right. the world trade organization and, what happened with airbus, subsidies. i'm trying to understand, the gist of what you wrote here, are you saying that the right way to do this is go through the world trade organization? >> it doesn't have to be the world trade organization as currently constituted. there are a lot of things we would like to improve its functioning but the basic issue you have a multilateral approach with a third party that looks at the facts says, that is not fair. the airbus subsidies were not fair. there is process laid out, rules, these are rules that the u.s. congress signed on to. we joined the wto you follow those rules. at the end of the day there is the chance there will be tariffs imposed on e of the products but they control their destiny. if they stop the practices, got them in trouble, the tariffs go away. that is really different situation we find ourselves with th

eakin, please. >> thank you for the update.e been thinking a lot about vision zero recently and just how many of the fatalities are pedestrians, not just in this year's data, but in the previous years. in thinking about the conversation we've had with respect to bicycles and the desire to continually upgrade to a protected bicycle facility, and thinking that that conversation, that thread, has stayed pretty relevant when it comes to pedestrians. thinking about this idea that you are waiting across the street, then you get the little walkman and he says go. there is a signal, i believe it says it is safe for you to be here at this time and in this place. the problem with allowing the right turn to cross that space -- it is truly not always safe. i think about this because my daughter is starting to walk home from school by herself. it is not always safe to be a pedestrian in that place and at that time. when you have left turning cars, you have right turning cars. you actually have to be on guard as a pedestrian in the crosswalk

director eakin, thank you for calling out engineering, we need to strive towards engineering streetshat preclude these known, dangerous and fatal behaviors. we can do that so the pilot program is a very exciting idea, a very exciting tool to start doing that faster and preventative non reactive way and i want to push this board and will continue to do so, to include as many aggressive engineering solutions in that pilot program so we can have things like turn restrictions at intersections, so we can things like protected intersections. whatever it is, these things we know make the streets safer so you would be included in the pilot program but we're excited to see that move forward and we'll be happy to speak more to it in two week's time. >> thank you, very much. >> mike spain. >> nice to see you. >> last person to turn in a speaker card. >> enforcement. it was brought up. i know what it means. driver reeducation and we talk about picketing drivers. as if that is really going to help. they've been ticketing people for make nothing left turns or wrong left turns since i came here. i

douglas holtz-eakin on issue you should be concerned about. the infrastructure is not important, keeping lights on, social security, medicare, payments on the debt is far more pressing issue and global implications. you can say infrastructure not so much. >>> qualcomm getting really real walloped here on antitrust ruling that did not go its way. here is the fear on the qualcomm ruling, that it will have pervasive effect on technology in general. i'm working to keep the fire going for another 150 years. ♪ for beauty that begins with nature. ♪ to make connections of a different kind. at adp we're designing a better way to work, so you can achieve what you're working for. but allstate actually helps you drive safely... with drivewise. it lets you know when you go too fast... ...and brake too hard. with feedback to help you drive safer. giving you the power to actually lower your cost. unfortunately, it can't do anything about that. now that you know the truth... are you in good hands? at comcast, we didn't build the nation's largest gig-speed net

and jake, the speech is taking place here in eakins oval, right near those famous rocky steps. >> arlette city of philadelphia. as biden holds on to his front-runner status, a first for bernie sanders and his own 2020 campaign. what is it? stay with us. billions of mouths. billions of problems. dry mouth? parched mouth? cotton mouth? there's a therabreath for you. therabreath oral rinse and lozenges. help relieve dry mouth using natural enzymes to soothe and moisturize. so you can... breathe easy, there's therabreath at walmart. if you have moderate to little things can be a big deal. that's why there's otezla. otezla is not a cream. it's a pill that treats plaque psoriasis differently. with otezla, 75% clearer skin is achievable. don't use if you're allergic to otezla. it may cause severe diarrhea, nausea, or vomiting. otezla is associated with an increased risk of depression. tell your doctor if you have a history of depression or suicidal thoughts or if these feelings develop. some people taking otezla reported weight loss. your doctor should monitor your weight and may stop treatment.